Skip to main content
Premium Trial:

Request an Annual Quote

BioServe Starts Multi-Center Sample Network

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomics services company BioServe said today that it has started a biosample repository network with several biomedical research institutions to provide customers with access to a large supply of samples for most major diseases.

The BioServe Network (BSN) will offer biosample access to BioServe's Global Biorepository and to biorepositories at its four BSN partners, including the Fox Chase Cancer Center, the Windber Research Institute, the University of Massachusetts Medical School and the Fairbanks Institute for Healthy Communities.

"Biosamples are an important research tool that can dramatically accelerate basic science, clinical research, and translational studies," BioServe President Rama Modali said in a statement.

BioServe noted that the BSN provides disclosure on where and how its samples were sourced, and said that the samples are collected using the highest standard operating protocols.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.